NS-9

N/A

Report date: 2024/09/11 20:00:38
NME

Base Information

Drug NameNS-9
Drug Alias NameNS-9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasm Recurrence, LocalNeoplasm MetastasisLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNs Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNs Pharma Inc
Active IndicationsN/A
Inactive IndicationsNeoplasm Recurrence, LocalNeoplasm MetastasisLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A